![Christopher Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd. from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd. from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Anciens postes connus de Christopher Parker
| Sociétés | Poste | Fin |
|---|---|---|
| ANTEOTECH LIMITED | Directeur Général | 01/12/2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | 01/07/2017 |
Formation de Christopher Parker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnteoTech Ltd.
 AnteoTech Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes proprietary surface coatings for health care & life sciences | Health Technology |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
